CVS Hits Pfizer With Antitrust Suit Over Lipitor Delay
CVS Pharmacy Inc. launched an antitrust suit in New Jersey federal court Friday accusing Pfizer Inc. of fraudulently obtaining a patent and conspiring with Ranbaxy Laboratories Ltd. to delay generic competition...To view the full article, register now.
Already a subscriber? Click here to view full article